Growth Metrics

Invivyd (IVVD) Non-Current Assets (2021 - 2025)

Invivyd posted quarterly Non-Current Assets of $29.4 million for Q4 2025, up 2.02% year-on-year from $28.8 million in Q4 2024, and little changed on a QoQ basis from $29.4 million in Q3 2025.

Invivyd (IVVD) has 5 years of Non-Current Assets data on file, last reported at $29.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets rose 2.02% year-over-year to $29.4 million; the trailing twelve-month figure through Dec 2025 stood at $116.6 million (up 135.16% YoY), and the FY2025 full-year result was $29.4 million, up 2.02% from the prior year.
  • Non-Current Assets for Q4 2025 stood at $29.4 million, roughly flat from $29.4 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $29.9 million in Q2 2025 and bottomed at $1.9 million in Q2 2021.
  • The 5-year median for Non-Current Assets is $5.6 million (2024), against an average of $11.2 million.
  • The widest annual swing landed in 2022, when Non-Current Assets slumped 48.47%; it then jumped 588.74% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $3.4 million in 2021, then soared by 84.91% to $6.2 million in 2022, then plunged by 31.2% to $4.3 million in 2023, then surged by 570.56% to $28.8 million in 2024, then climbed by 2.02% to $29.4 million in 2025.
  • The last three Non-Current Assets figures came in at $29.4 million (Q4 2025), $29.4 million (Q3 2025), and $29.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 4.56 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 62,953.78
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 486.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 5.83 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.75 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 22.66 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 910.24 Mn
10 Invivyd 208.38 Mn -18.31 Mn - 29.42 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 29.42 Mn
Sep 30, 2025 29.39 Mn
Jun 30, 2025 29.86 Mn
Mar 31, 2025 27.92 Mn
Dec 31, 2024 28.83 Mn
Sep 30, 2024 10.82 Mn
Jun 30, 2024 4.34 Mn
Mar 31, 2024 5.59 Mn
Dec 31, 2023 4.30 Mn
Sep 30, 2023 4.81 Mn
Jun 30, 2023 5.43 Mn
Mar 31, 2023 5.94 Mn
Dec 31, 2022 6.25 Mn
Sep 30, 2022 3.15 Mn
Jun 30, 2022 3.25 Mn
Mar 31, 2022 1.97 Mn
Dec 31, 2021 3.38 Mn
Sep 30, 2021 6.12 Mn
Jun 30, 2021 1.93 Mn